放射性碘治疗甲状腺乳头状癌。
Radioactive Iodine for Papillary Thyroid Carcinoma.
机构信息
Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
出版信息
Methods Mol Biol. 2022;2534:225-241. doi: 10.1007/978-1-0716-2505-7_16.
PMID:35670979
Abstract
Radioactive iodine is given after total thyroidectomy for remnant ablation or treatment of residual/metastatic disease. The decision and dose of radioactive iodine should be in a personalized and patient-specific approach, taking account the clinical-pathological features, risk stratification, patient's preference, and facilities of the institutions. We review the principles and use of radioactive iodine in differentiated thyroid cancer.
摘要
放射性碘在甲状腺全切术后用于残余消融或治疗残留/转移性疾病。放射性碘的决策和剂量应采用个性化和患者特异性的方法，考虑临床病理特征、风险分层、患者偏好和医疗机构的设施。我们回顾了分化型甲状腺癌中放射性碘的原则和应用。
Zotero 插件